Attune Neurosciences

Oct 29, 2024 | journals.plos.org | Keith Murphy |Attune Neurosciences |Elsa F. Fouragnan

Towards the future of TUSWhile early therapeutic TUS may be entirely relegated to clinical settings with highly regimented treatment strategies and technician operations, more complex use-cases will likely develop over time. However, the trajectory of these developments relies heavily on the incremental success of early approved indications.